IRRIV International Renal Research Institute Vicenza
Avatar

Biomarkers of Glomerulonephritis

By IRRIV International Renal Research Institute Vicenza FEATURING Claudio Ronco
November 7, 2017
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
19:33
ARCH Advanced Revascularization Symposium

Contrast Nephropathy

14:51
San Diego Cardiovascular Interventions (SDCI) 2019

Avoiding Contrast Induced Nephropathy

Feat. P. Meraj
18:05
AKI & CRRT Conference

What's New in ARDS?

21:40
35th Vicenza Course on AKI and CRRT

Fluid Management in AKI

Feat. R. Mehta
47:02
John Kellum

Acute Kidney Injury and AKI Biomarkers in the ICU

18:57
AKI & CRRT Conference

Personalized Bp Management to Optimize Organ Perfusion

Feat. M. Pinsky
19:35
35th Vicenza Course on AKI and CRRT

Use of Diuretics

Feat. R. Bellomo
13:33
AKI & CRRT Conference

Does Hypoalbuminema Cause AKI?

Feat. M. Joannidis
04:38
Mayo Clinic Proceedings

Renal Impairment Update: Can We Use Inclisiran Without Dose Adjustments?

Feat. R. Wright
23:37
Heart of Battle: Sentara Shock Symposium

Water Water Everywhere: Decongestion in Heart Failure

Feat. R. Starling
28:48
University of Pittsburgh AKI Symposium 2017

AKI: A Patient's Perspective

18:52
38th Vicenza Course on AKI and CRRT

How CARPEDIEM Helps Increase Adoption of Continuous Renal Replacement Ther…

Feat. E. Vidal
19:02
AKI & CRRT Conference

Assessing Renal Recovery after AKI: Can Biomarkers Help?

02:38
IRRIV International Renal Research Institute Vicenza

Drug Clearance in CRRT

Feat. C. Ronco
14:35
AKI & CRRT Conference

Preventing AKI in the ICU: Current Guidelines

Feat. M. Joannidis
15:07
35th Vicenza Course on AKI and CRRT

Personalized Blood Pressure Targets: Finding the Optimal Perfusion Pressure

Feat. M. Pinsky
24:30
35th Vicenza Course on AKI and CRRT

Vasopressin-2 Receptor Blockers - Mechanism of Action and Clinical Utility

Feat. Q. Qian
20:20
35th Vicenza Course on AKI and CRRT

Pathways towards Kidney Recovery after AKI

Feat. J. Kellum
29:47
AKI & CRRT Conference

Vasopressin: A Novel Target for Prevention and Retardation of Kidney Disea…

16:07
35th Vicenza Course on AKI and CRRT

From AKI to CKD - Maladaptive Repair or Inevitable Destiny?

Feat. G. Castellano